Search - tctmd.com

Displaying 101 - 120 of 362

Sort: Relevancy | Date

News Conference News AHA 2022

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Michael O'Riordan

November 07, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

Low-Carb Diet Promising for Lowering Blood Sugar in Prediabetes

L.A. McKeown

October 28, 2022

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

Acute Chest Pain in the ED? SCCT Offers Guidance for Using CTA

News Daily News

Acute Chest Pain in the ED? SCCT Offers Guidance for Using CCTA

Yael L. Maxwell

October 06, 2022

News Daily News

Older Adults See Rebound in Rates of HF-Related Death: CDC Data

Caitlin E. Cox

September 09, 2022

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Daily News

US, European Hypertension Guidelines: More Alike Than Different

Caitlin E. Cox

August 17, 2022

News Daily News

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

Yael L. Maxwell

August 16, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Daily News

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

Todd Neale

August 12, 2022

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

News Daily News

USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits

Michael O'Riordan

July 27, 2022

News Daily News

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

Todd Neale

July 20, 2022

Advertisement

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Low-Carb Diet Promising for Lowering Blood Sugar in Prediabetes

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Acute Chest Pain in the ED? SCCT Offers Guidance for Using CCTA

Older Adults See Rebound in Rates of HF-Related Death: CDC Data

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

US, European Hypertension Guidelines: More Alike Than Different

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content